Application

PTO- 1478

Approved for use through 08/31/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 08/31/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90864504

Filing Date: 08/04/2021

To the Commissioner for Trademarks:

MARK: YOU DESERVE BRAVE SCIENCE (Standard Characters, see mark)
The literal element of the mark consists of YOU DESERVE BRAVE SCIENCE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Neurocrine Biosciences, Inc., a corporation of Delaware, having an address of
      12780 El Camino Real
      San Diego, California 92130
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Research and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing medical information; providing medical information in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Allison Strickland Ricketts. Other appointed attorneys are all other attorneys in firm. Allison Strickland Ricketts of Fross Zelnick Lehrman & Zissu, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      151 West 42nd St., 17th Floor
      New York, New York 10036
      United States
      ricketts-docket@fzlz.com
The docket/reference number is NEUB 2109700.
Allison Strickland Ricketts submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Allison Strickland Ricketts

PRIMARY EMAIL FOR CORRESPONDENCE: ricketts-docket@fzlz.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): antonucci-docket@fzlz.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /David L. Bradfute/   Date: 08/04/2021
Signatory's Name: David L. Bradfute, PhD, JD
Signatory's Position: Vice President & Head, Intellectual Property
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90864504
Payment Accounting Date: 08/04/2021

Serial Number: 90864504
Internet Transmission Date: Wed Aug 04 11:26:46 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2021080411264651
4387-90864504-78169071c6c8daf68518d2c9f4
9de43d85be116517616c0d5532520f53411344-D
A-26462211-20210804095826406085